12.5 Outdated, Deteriorated & Recalled Drugs: Conditions Prohibiting Dispensing
Key Takeaways
- Rule 1140-03-.11 requires the owner or pharmacist in charge to immediately return or destroy all outdated, defective, or deteriorated prescription drugs, devices, and related materials.
- Destruction of controlled substances listed in any schedule must be performed by a Board-approved agent or vendor, not by pharmacy staff acting on their own.
- Rule 1140-03-.10(1) bars any package damaged by fire, heat, smoke, water, or other causes from being placed in stock, offered for sale, dispensed, or otherwise sold, and requires Board approval for repossession proceedings.
- Rule 1140-03-.10(2) prohibits delivering damaged product to an insurance company, adjustor, salvage company, or any other person unless the Board approves prior to delivery.
- FDA recall classes turn on health consequence: Class I involves a reasonable probability of serious adverse health consequences or death, Class II a temporary or medically reversible consequence, and Class III a violation unlikely to cause adverse health consequences.
12.5 Outdated, Deteriorated & Recalled Drugs: Conditions Prohibiting Dispensing
Quick Answer: NABP Competency 3.7 asks what conditions of the drug product itself prohibit dispensing. Tennessee answers with two short, absolute rules. Rule 1140-03-.11 requires the owner or pharmacist in charge to immediately return or destroy all outdated, defective, or deteriorated prescription drugs, devices, and related materials — "except that the destruction of controlled substances listed in any schedule shall be performed by a Board approved agent or vendor." Rule 1140-03-.10(1) bars any package damaged by fire, heat, smoke, water, or other causes from being placed in stock, offered for sale, dispensed, or otherwise sold, and Rule 1140-03-.10(2) forbids handing such product to an insurer, adjustor, or salvage company unless approved by the Board prior to delivery.
1. Outdated, Defective and Deteriorated Stock — Rule 1140-03-.11
The rule is a single sentence, and each element is testable:
| Element | Detail |
|---|---|
| Who bears the duty | The owner or the pharmacist in charge — the obligation is not confined to the PIC |
| What is covered | Prescription drugs and devices and related materials that are outdated, defective, or deteriorated |
| What must happen | Immediately return or destroy — there is no authorized holding period |
| Controlled substance carve-out | Destruction of controlled substances in any schedule must be performed by a Board approved agent or vendor |
"Immediately" is doing real work. A quarantine bin of expired stock awaiting the next reverse-distributor pickup is defensible only if the segregated product is genuinely in transit to return or destruction; a bin that functions as long-term storage is a citation. The phrase "return or destroy" also matters: returning outdated stock to the wholesaler or a registered reverse distributor is an accepted disposition, not a lesser alternative to destruction.
The Controlled Substance Destruction Chain
┌─────────────────────────────────────────────────────────────────────────────┐
│ DISPOSITION OF EXPIRED / UNUSABLE CONTROLLED STOCK IN A TN PHARMACY │
├─────────────────────────────────────────────────────────────────────────────┤
│ Registrant-owned stock (NOT patient returns) │
│ │ │
│ ├─> TRANSFER to a DEA-registered REVERSE DISTRIBUTOR │
│ │ • Schedule II -> documented on a DEA Form 222 (or CSOS) │
│ │ • Schedules III–V -> documented on invoices │
│ │ • TN overlay: the agent/vendor must be BOARD APPROVED │
│ │ │
│ └─> ON-SITE DESTRUCTION under 21 CFR Part 1317 │
│ • Recorded on DEA Form 41 │
│ • Rendered NON-RETRIEVABLE │
│ • TN overlay: performed by a BOARD APPROVED agent or vendor │
│ │
│ Patient-returned medication │
│ └─> NEVER re-enters stock; take-back only, under 21 CFR Part 1317 and │
│ Rules 1140-03-.03(8)(b) and 1140-03-.10(3). See § 8.6. │
└─────────────────────────────────────────────────────────────────────────────┘
The Tennessee overlay is the frequently missed piece. Federal law permits a registrant to destroy its own controlled stock on site in a manner rendering it non-retrievable, recorded on DEA Form 41. Tennessee narrows that: Rule 1140-03-.11 directs that destruction of controlled substances in any schedule be performed by a Board-approved agent or vendor. When federal and state law both apply and the state is stricter, the state standard governs the Tennessee pharmacist.
2. Fire-, Water- and Smoke-Damaged Product — Rule 1140-03-.10(1) and (2)
Rule 1140-03-.10 is captioned Conditions for Delivery or Sale, which disguises how much of Competency 3.7 it carries.
- (1) No re-entry into commerce. "No package containing any prescription drug or device or related material damaged by fire, heat, smoke, water, or other causes shall be placed in stock, offered for sale or dispensed or otherwise sold. Any repossession proceedings must be performed with the approval of the board."
- (2) No hand-off to insurers or salvagers. "Under no circumstances shall any prescription drug or device or related material damaged by fire, heat, smoke, water, or other causes be delivered or handed over to any insurance company, adjustor, salvage company, or other person unless approved by the board prior to delivery."
The catch-all "or other causes" is broad by design. A refrigerator failure that takes insulin outside its labeled range, a shipment left on a loading dock in July heat, and a sprinkler discharge all land inside paragraph (1). The practical sequence after a loss event is therefore: quarantine → notify the Board (Rule 1140-03-.09 for robbery, embezzlement, theft, burglary, fire, or disaster) → obtain Board approval before any transfer to an insurer or salvager → dispose through the Rule 1140-03-.11 pathway.
3. Recalls
A recall is a third condition prohibiting dispensing, and it is federal in origin. FDA classifies recalls by the health consequence of the violative product:
| Class | Standard | Practical pharmacy response |
|---|---|---|
| Class I | A reasonable probability that use of, or exposure to, the product will cause serious adverse health consequences or death | Quarantine immediately; identify and notify affected patients; document the notification |
| Class II | Use may cause temporary or medically reversible adverse health consequences, or the probability of serious consequences is remote | Quarantine; patient notification per the recall notice and professional judgment |
| Class III | Use is not likely to cause adverse health consequences, but the product violates FDA regulations | Quarantine and return per the notice; patient-level notification generally not indicated |
Recalls may be initiated by the firm voluntarily or at FDA's request, and FDA has mandatory recall authority for certain product categories. A market withdrawal (a minor violation FDA would not take action against) and a stock recovery (product that never left the manufacturer's control) are distinct from recalls and should not be confused with them on an exam item.
Once a recall notice reaches the pharmacy, the recalled lots are adulterated or misbranded product for dispensing purposes. Continuing to dispense them exposes the pharmacy to liability under 21 U.S.C. § 351 (adulteration — concerning the strength, purity, quality, or conditions of preparation) or 21 U.S.C. § 352 (misbranding — concerning labeling and required disclosures), and to Tennessee discipline under T.C.A. § 63-10-309(3) for conduct prohibited under Title 63, Chapter 10 or other law relating to drugs.
4. Beyond-Use and Expiration: When a Product Becomes "Outdated"
Three different dates can render a product undispensable, and Competency 3.7 items often turn on distinguishing them:
| Date | Set by | Applies to | Where it appears |
|---|---|---|---|
| Manufacturer expiration date | The manufacturer, from stability data | The unopened original container | Rule 1140-03-.06 requires the product's expiration date on the dispensing label if applicable |
| Beyond-use date for repackaged product | The pharmacy | Product moved out of the original container | Governed by USP repackaging standards; conventionally one year from repackaging or the manufacturer expiration, whichever is earlier |
| Beyond-use date for compounded preparations | The pharmacy, per USP | Compounded non-sterile and sterile preparations | USP <795> and USP <797> default tables — see §§ 10.1 and 10.2 |
Whichever date governs, the assigned date may never exceed the shortest expiration date of any component, and once it passes the product is "outdated" for purposes of Rule 1140-03-.11 and must be immediately returned or destroyed.
5. Practical Exam Scenarios
Scenario 1: The Quarantine Shelf
Case: An inspector finds a shelf in the pharmacy labeled "EXPIRED — DO NOT DISPENSE" holding roughly 60 bottles of assorted legend drugs, some expired for more than a year, awaiting a reverse distributor pickup that the PIC schedules annually. Legal Analysis: Segregation is necessary but not sufficient. Rule 1140-03-.11 requires the owner or PIC to immediately return or destroy outdated stock. An annual pickup cycle turns the quarantine shelf into a storage location rather than a transit point, and the accumulation of product expired for more than a year is direct evidence that the immediacy requirement is not being met.
Scenario 2: The Adjuster at the Door
Case: After a sprinkler discharge soaks part of the prescription department, the pharmacy's insurance adjuster asks to take the wet stock the same afternoon so the claim can be processed quickly. Legal Analysis: The pharmacy must refuse pending Board approval. Rule 1140-03-.10(2) states that "under no circumstances" may damaged prescription product be delivered or handed over to an insurance company, adjustor, salvage company, or other person "unless approved by the board prior to delivery." The pharmacy should also make the immediate report required by Rule 1140-03-.09, since a sprinkler discharge is a disaster resulting in loss of prescription drugs, and must include a list with amounts.
Scenario 3: The Class I Recall
Case: A Class I recall is issued for three lots of an implantable-adjacent device the pharmacy has dispensed to 14 patients over the past eight months. Legal Analysis: A Class I classification means there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death, which makes patient-level notification the expected response rather than a discretionary one. The pharmacy quarantines remaining stock immediately, identifies affected patients from the record system required by Rule 1140-03-.01(2), notifies them and their prescribers, documents each notification, and disposes of the recalled stock per the recall notice and Rule 1140-03-.11.
Under Tenn. Comp. R. & Regs. 1140-03-.11, who bears the duty regarding outdated, defective, or deteriorated prescription drugs, and what must be done?
Water from a burst pipe soaks several cases of prescription stock. Which action is expressly prohibited by Tenn. Comp. R. & Regs. 1140-03-.10?
FDA issues a recall for a product where use is not likely to cause adverse health consequences but the product violates FDA regulations. How is this classified?
A Tennessee pharmacy's PIC wants to destroy expired Schedule II tablets on site, rendering them non-retrievable and recording the destruction on a DEA Form 41. Is this sufficient?
You've completed this section
Continue exploring other exams